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Abstract. Type II collagen is a major component of
cartilage providing structural integrity to the tissue.
Type II procollagen can be expressed in two forms by
differential splicing of the primary gene transcript.
The two mRNAs either include (type IIA) or exclude
(type IIB) an exon (exon 2) encoding the major por-
tion of the amino (NH2)-propeptide (Ryan, M. C., and
L. J. Sandell. 1990. J. Biol. Chem. 265:10334-10339).
The expression of the two procollagens was examined
in order to establish a potential functional significance
for the two type II procollagen mRNAs. First, to es-
tablish whether the two mRNAs are functional, we
showed that both mRNAs can be translated and the
proteins secreted into the extracellular environment.
Both proteins were identified as type II procollagens.
Secondly, to test the hypothesis that differential ex-
pression of type II procollagens may be a marker for a
distinct population of cells, specific procollagen
mRNAs were localized in tissue by in situ hybridiza-
tion to oligonucleotides spanning the exon junctions.
Embryonic vertebral column was chosen as a source
of tissue undergoing rapid chondrogenesis, allowing
the examination of a variety of cell types related to
cartilage. In this issue, each procollagen mRNA had a
distinct tissue distribution during chondrogenesis with
type IIB expressed in chondrocytes and type IIA ex-
YPE II collagen is the predominant collagenous compo-
nent of cartilage composing >50 % of the extracellular
matrix. Like type I collagen, the most abundant col
lagen in vertebral organisms, it is an interstitial collagen'
synthesized as a procollagen monomer, assembled into mo-
lecular trimers and processed extracellularly to remove NH2-
and COON-terminal extension propeptides. The interstitial
1. Interstitial collagens, also called Group 1 collagens, are defined as the
major fibril-forming collagens by Miller, E. J. and S. Gay (1987. Methods
Enzymol. 144:3-40) and include types 1, II, III, V, and XI.
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pressed in cells surrounding cartilage in prechondro-
cytes. The morphology of the cells expressing the two
collagen types was distinct: the cells expressing type
IIA are narrow, elongated, and "fibroblastic" in appear-
ance while the cells expressing type IIB are large and
round . The expression of type IIB appears to be cor-
related with abundant synthesis and accumulation of
cartilagenous extracellular matrix . The expression of
type IIB is spatially correlated with the high level ex-
pression of the cartilage proteoglycan, aggrecan, estab-
lishing type IIB procollagen and aggrecan as markers
for the chondrocyte phenotype. Transcripts of type II
collagen, primarily type IIA, are also expressed in
embryonic spinal ganglion. While small amounts of
type II collagen have been previously detected in non-
cartilagenous tissues, the detection of this new form of
the collagen in relatively high abundance in embryonic
nerve tissue is unique. Taken together, these findings
imply a potential functional difference between type
IIA and type IIB procollagens and indicate that the
removal of exon 2 from the pre-mRNA, and conse-
quently the NH2-propeptide from the collagen mole-
cule, may be an important step in chondrogenesis. In
addition, type II procollagen, specifically type IIA,
may function in noncartilage tissues, particularly dur-
ing development.
collagen monomer contains a non-interrupted Gly-XY pro-
tein domain of -1,014 amino acids, flanked by the globular
propeptides. The COOH-terminal propeptide of ti 275 amino
acids is connected to the main triple helix by a short telopep-
tide, is highly conserved between interstitial collagens, and
is thought to be involved in initiation of trimer formation.
The NH2-terminal propeptide shows more structural and
sequence diversity among the interstitial collagens, but gen-
erally consists of a short globular domain followed by a cys-
teine-rich domain, a Gly-XY domain of40-60 residues, and
a short connecting telopeptide (Sandell and Boyd, 1990) . Ithas been suggested that the propeptides, particularly the
NH2-propeptide, are involved in feedback regulation of col-
lagen synthesis and in the formation of fibrils in the extracel-
lularmatrix (Wiestner et al ., 1979; Wu et al., 1986; Fleisch-
majer et al., 1983) .
Traditionally, the presence of type II collagen has served
as a marker for cartilage, however, small amounts of type II
collagen have been detected at the epitheliomesenchymal in-
terfaces during morphogenesis of the cartilaginous neu-
rocranium and in other noncartilaginous tissues of develop-
ing chicken embryos (Linsenmayer et al ., 1977; von der
Mark et al ., 1977; Newsome et al., 1976; Smith et al., 1976;
Linsenmayer and Little, 1978 ; Kosher and Solursh, 1989).
In prechondrogenic limb mesenchymal cells, type II colla-
gen mRNA has been detected prior to the onset of overt car-
tilage differentiation and before accumulation of detectable
amounts of type II collagen (Kravis and Upholt, 1985; Ko-
sher et al ., 1986) . Kosher et al. (1986) suggested that low
level expression of type II collagen gene by chondrogenic
progenitor cells may represent a molecular manifestation of
the state of determination of the cells, however, the role of
type II collagen in prechondrocytic and nonchondrocytic
cells is not known.
Recently, two type II procollagen transcripts were found
to be produced from the single COL2A1 gene (Ryan and
Sandell, 1990). We reported the finding of an exon (exon2)
present in the humanCOL2A1 gene (Ryan et al ., 1990) that
was not present in type II collagen cDNA clones from human
chondrocytes (Baldwin et al., 1989) or rat chondrosarcoma
(Kohno et al., 1984). This exon encodes the collagenase
resistant, cysteine-rich domain of the NH2-propeptide. The
protein domain contains 69 amino acids, including 10 cys-
teine residues, is conserved between interstitial collagens
chains al(I), al(II), al(III), a2(V), and is homologous to a
domain present in the extracellular matrix proteins throm-
bospondin and von Willebrand factor (Ryan and Sandell,
1990). Further investigation of type II procollagen mRNA
transcripts revealed that this domain is expressed in em-
bryonic and adult chondrocyte mRNA populations and is
subject to alternative splicing in the pre-mRNA (Ryan and
Sandell, 1990) . Northern blot analysis usingoligonucleotide
probes spanning the boundaries between exon 1 and exon 2
(type IIA) or exon 1 and exon 3 (type IIB) indicated that type
IIB mRNA was the predominant form expressed in RNA iso-
lated from cartilage cells although both mRNAs were present
in the RNA populations examined. We suggested that the ex-
pression of exon 2 may be a marker for a distinct population
of cells and have designed this study to test that hypothesis.
The expression of the two procollagens was examined in
medium from cultured juvenile costal chondrocytes (shown
previously to express both type II procollagen mRNAs).
These cells translated and secreted both type II procollagens
at relativelyhigh levels. Identification ofthe cells synthesiz-
ing the two type II procollagens was accomplished by in situ
hybridization to mRNA using oligonucleotide probes de-
signed to identify specific mRNAs.
Materials and Methods
CellCultures
Procollagens were isolated from medium of human costal chondrocytes.
Costal cartilage was obtained from ribs removed during pectus excavatum
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repair. Chondrocytes were isolated by dispersion with proteases as follows.
Cartilage slices were incubated at 37°C with hyaluronidase (1 mg/ml in
PBS; bovine testicular from Sigma Chemical Co., St. Louis, MO, for 10
min, followed by 0.25% trypsin (GIBCO/BRL, Gaithersburg, MD) for 45
min). The cartilage was then chopped in small fragments and incubated at
37°C with collagenase (3 mg/ml in serum-free culture medium, clostridial
peptidase from Worthington Biochemical Corp., Freehold, NJ) for 24 h for
articular cartilage or48 h for costal cartilage. The dispersed cells were then
washed with Ca"- and Mgr-free PBS and cultured in Dulbecco's
modified Eagle's medium supplemented with 10% FCS with medium
changes every 3-4 d, as described previously (Goldring et al., 1986).
Costal chondrocytes from two different individuals (C-29: 16-yr-old fe-
male, 16 d of culture; C-30: 6-yr-old female, 8 d ofculture) were used for
the experiments described in this study. The cells were labeled 24 h after
thelastmedium changefor a further 24 h in serum-free Dulbecco's modified
Eagle's medium (5 ml per 10-cm dish) supplemented with 50 kg/ml ascor-
bate and 50 pg/ml ß-aminoproprionitrile fumarate and containing 25 pCi/
ml of [3H]proline (>20 Ci/mmol; Amersham Corp., Arlington Heights,
IL) and 50 pCi/ml of [35S]cysteine (1071 Ci/mmol; Amersham Corp.).
IsolationofProcollagens
The culture medium containing [3H]proline labeled proteins was adjusted
to 5 mM EDTA, and 1 mM N-ethylmaleirnide. Proteins were precipitated
by the addition of 300 mg/ml of ammonium sulfate which was stirred over-
night at4°C. Theprecipitate was collected by centrifugation at 15,000 rpm,
4°C, for 30 min in an SS 34 rotor (Sorvall Instruments, Newton, CT) using
an RC 5C centrifuge (Sorvall Instruments). The precipitate was suspended
in 0.05 M Tris-HCI, pH 7.5, 0.25 M NaCl, 0.1% Triton X-100. The samples
were treatedwith 0.25 % diisopropyl fluorophosphate for 4h on ice and then
dialyzed againstthe samebuffer. Samples were runover a Sepharose-gelatin
column (Pharmacia Fine Chemicals, Piscataway, NJ) to removefibronectin.
When indicated, aliquots were digested with purified bacterial collagenase
(Morris et al., 1983) or pepsin. Labeled proteins were visualized by
fluorography after separation on SDS-PAGE (Burgeson et al., 1976) using
Amplify (Amersham Corp.). Cyanogen bromide peptide mapping of gel
bands was performed according to the method of Sokolov et al,. (1989)
using the 16-h incubation. Human type I procollagen was prepared from the
medium of primary skin fibroblasts incubated with [3H]proline (Amer-
shamCorp.) for 24h. The mediumwas precipitated with ammonium sulfate
and treated with diisopropyl fluorophosphate as described above. The sam-
ple was then fractionated under nondenaturing conditions on a Sepharose-
6B column (Pharmacia Fine Chemicals) and the fractions containing type
I procollagen pooled and frozen. [3H]Proline-labeled mixture of chick
types II and XI collagen was obtained from organ culture of chick sterna
as previously described (Morris and Bachinger, 1987). Labeling was for 60
min and purification proceeded only to passage over DEAF cellulose to re-
move proteoglycan. Unless otherwise indicated, all reagents were pur-
chased from Sigma Chemical Co.
InSitu Hybridization
Tissue used in this study was human fetal vertebral column, 57-d gestation,
(Carnegie Stage 23), provided by the Central Laboratory for Human Em-
bryology at the University of Washington. The age was determined from
crown to rump length by the method of Shepard (1975). Tissue was frozen
in O.C.T. compound (Miles Laboratories Inc., Elkhart, IL) and sectioned
with a cryostat, or fixed in 4% paraformaldehyde, embedded in Epon, and
sectioned on a microtome. For in situ hybridization, frozen sections were
used within situ hybridization procedures described by Lewis etal., (1985).
In brief, slides with a single section of vertebral tissue (6-10 lim) were
warmed to room temperature. Sections are postfixed in 4% paraformalde-
hyde, treated with acetic anhydride (0.25% in 0.1 M triethanolamine), de-
hydrated, delipidated, and air dried. An 35S-labeled oligonucleotide probe
was added to hybridization buffer containing 50% deionized formamide,
10% dextran sulfate, 300 mM NaCl, 10 mM Tris, 1 mM EDTA, Ix Den-
hardt's (0.02 % each ofBSA, Ficoll, andpolyvinylpyrollidone), 0.5 mg yeast
tRNA/ml, and 10 mM dithiothreitol. A 45-Pl aliquot (containing 2.5 pmol
of probe/ml) was applied to the slide. Specific activity estimates ranged
from 1.0 to 1.2 x 107 cpm/pmol. Sections were coverslipped and slides
were incubated overnight in moist chambers at 37°C. After the overnight
incubation, coverslips were removed and sections washed four times in lx
standard saline citrate (lx SSC = 150 mM NaCl, 15 mM sodium citrate)
for 15 min at 50°C. In some cases, stringency was increased by elevating
wash temperatures. Slides were washed twice for 1 h at room temperature.
The sections were dehydratedthroughagraded series ofalcohols containing
300 mM ammonium acetate and exposed to Hyperfilm BMax (Amersham
1308Corp.) for 3 d. Slides were dipped in NTB 2 emulsion (Eastman Kodak Co.,
Rochester, NY), diluted 1:1 with 600 mM ammonium acetate and exposed
for 8-12 d. The emulsion was developed in D-19 (Eastman Kodak Co.),
diluted 1:1 with distilled water at 16°C. Sections were counterstained with
cresylviolet acetate and coverslipped. Autoradiographs wereanalyzed with
the aid of a MCID Image Analysis System (Imaging Research, St. Catha-
rines, Ontario, Canada).
OligonucleotideProbes
Probes specific for type IIA and type IIB collagen have been described
(Ryan and Sandell, 1990) and contain the following. For type IIA, 12
nucleotides of exon 1 and 12 nucleotides ofexon 2, 5'-TGCCAGCCTCCT
GGACATCCTGGC-3; for type IIB, 12 nucleotides ofexon 1 and 12 nucleo-
tides of exon 3, 5'-CTCCTGGTTGCCGGACATCCTGGC-3 . Other oligo-
nucleotides used in this report were the following. All type II collagen
mRNAs, a 21mer oligonucleotide of exon 8, 5'-GCCTTCTGATCAAAT
CCTCCA-3; aggrecan (nucleotides 1,096-1,120) of cDNA reported by
Baldwin et al. (1989), 5'-CTCGTGCCAGATCATCACCACACAT 3; al(I)
procollagen, exon 1/exon 2 junction, 5'-TGATTGGTGGGATGTCTTCGT
CTT3' (d'Alessio et al., 1988). Oligonucleotides were synthesized with a
DNA synthesizer (Applied Biosystems, Inc., Foster City, CA) and purified
by passage through a 5 % acrylamide gel; only the full-sized oligomers were
eluted. Oligonucleotides were labeled with 5'-[a-thiol-3551-ATP (New En-
gland Nuclear, Boston, MA) using terminal deoxynucleotidyl transferase
(Bio-Rad Laboratories, Gaithersburg, MD).
Results
Translation andSecretionofTwoProcollagens
Since mRNAs generated by alternative splicing of a gene are
not necessarily translated into functional proteins, it was
necessary to determine whether the two type II collagen
mRNAs could produce protein products. A diagram of the
COL2A1 gene, type IIA and type IIB procollagen mRNAs,
and the predicted procollagens is presented in Fig. 1. To de-
termine whether two procollagens could be translated from
the two mRNAs, media from cultures of freshly isolated ju-
venile costal chondrocytes were analyzed . These cells were
chosen for analysis because we had previously demonstrated
that they express both type IIA and type IIB collagen mRNAs
(Ryan and Sandell, 1990) and do not contain detectable lev-
els of type I collagen mRNA. Upon incubation of these cells
with [3H]proline, collagens and fibronectin were the most
prominent radiolabeled components due to the relatively
high content of proline in these matrix proteins.
Characterization of the two procollagen molecules and
processing intermediates secreted by these chondrocytes
demonstrated that they have the classical characteristics of
specific procollagens including sensitivity to degradation by
bacterial collagenase, pepsin sensitivity of the propeptide
domains, predicted migration patterns on SDS-PAGE with
and without reduction, and a cyanogen bromide peptide pat-
tern characteristic oftype II collagen. Fig. 2 A shows the pat-
tern ofcollagen chains separated by SDS-PAGE under reduc-
ing conditions. Previous analysis of sequence implied from
cDNA and genomic clones have shown that the NH2-
propeptide of type IIA (Ryan and Sandell, 1990; Su et al .,
1989), the C-propeptide (Sandell et al., 1984) and triple he-
lix (Sandell, et al., 1983 ; Upholt and Sandell, 1986) of type
II collagen are similar to those ofthe al chain oftype I colla-
gen in amino acid content and peptide length with one excep-
tion: the NH2-propeptide of type II procollagen contains a
longer Gly-XY domain (30 amino acids) than type I procol-
lagen. In analogy to al(I) collagen, four forms of the type
IIA chain were expected: pNC procollagen containing both
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Figure 1. Diagram of the COL2A1 gene, type IIA and type IIB
procollagen mRNAs, and type IIA and type IIB procollagens.
Exons are indicated as open boxes. Oligonucleotide probes specific
for type IIA or type IIB procollagen mRNA are indicated by bars
above the respective mRNAs and described in Methods. In the
procollagen molecules, SP is the signal peptide; NH2 is the
amino-terminal propeptide; TP is the telopeptide, Gly-XY indi-
catesthe triple helical domain, and COOH is the carboxy-terminal
propeptide. The regions indicated by a straight line are triple helical
and regions indicated by the curved lines are globular portions of
the protein. The differentially spliced domain is indicated by arrows
in the type IIA procollagen.
NHZ- and COOH-propeptides, pC collagen containing only
the COOH-propeptide, pN collagen containing only the
NHZ-propeptide, and the fully processed al(II) chain. With
the presence of two type II procollagens, an additional pNC
(without exon 2) and pN (without exon 2) procollagen is
predicted. Samples from two separate costal chondrocyte
cultures were analyzed. Passage through a gelatin-Sepharose
column removed fibronectin. Here, five collagenase-sensi-
tive bands were observed, one alpha chain and four bands
of procollagens. Under these reduced conditions, we predict
that the pN (+ exon 2) procollagen cannot be resolved from
the pC procollagen.
Subsequent analyses of the juvenile costal chondrocytes
were performed on sample C-30. To determine which of the
collagenase-sensitive bands 1-5 were procollagens, the sam-
ple was digested with pepsin under conditions whereby only
the globular domains of the procollagens would be removed.
Fig. 2 B shows the predicted pepsin resistance of the mature
collagen alpha chain and the pepsin sensitivity of the four
more slowly migrating bands: all predicted procollagens
(lane 2) were reduced to the size of alpha chains (lane 3).
To exclude the possibility that any of these bands could be
derived from type III procollagen, an interstitial collagen
that contains interchain pepsin-resistant disulfide bonds, the
digested sample was electrophoresed without prior reduction
of disulfide bonds (Fig. 2 B, lane 4) . The lack of trimeric
molecules (>300,000 D) after pepsin digestion and elec-
trophoresis under nonreducing conditions indicated that
there was no type III procollagen in the sample.
The analysis presented in Fig. 2 C was designed to visual-
ize the pN forms of type II procollagens. To resolve pN
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TPFigure 2. Identification of two
type II procollagens . (A) [3H]-
Proline-labeled components of
costal chondrocyte culture me-
dium . Samples were passed
through a gelatin-Sepharose
column and analyzed by SDS-
PAGE on a 5% gel before and
after digestion with bacterial
collagenase . Lane 1, sample
C30 ; lane 2, sample C30 +
bacterial collagenase; lane 4,
sample C29 ; lane 5, sample
C29 + bacterial collagenase .
Lanes 3 and 6 are aliquots of
material bound to gelatin seph-
arose (primarily composed of
fibronectin) from each of the
respective samples . Lane 7,
chick type II procollagen ; each
of the procollagen forms are
indicated and the upper and
lower bands are type XI and
type IX collagen chains, re-
spectively . All samples were
reduced with ß-mercaptoeth-
anol before electrophoresis .
(B) Analysis of humantype II
procollagen by SDS-PAGE af-
ter pepsin digestion . Pepsin
digestion oftype II procollagen
removes propeptides and yields
a single band corresponding
to the a chain . Sample C30,
shown inA, was digested with
pepsin as described in Materi-
alsandMethods and analyzed
by SDS-PAGE on a 5% gel .
Lane 1, isolated human type I
procollagen . Lane 2, sample
C30 . Lane 3, sample C30 di-
gested with pepsin . Lane 4,
sample C30 digested with pep-
sinand runwithout reduction
of disulfide bonds . The arrow
indicates the migration of
pNC a1(I) and type IIA pro-
collagens . (C)Analysis ofhu-
man type II procollagen by
SDS-PAGE without prior re-
duction of disulfide bonds .
To more clearly analyze the
pNa chains, sample C30 was
electrophoresed on a 5% gel
without reduction of disulfide
bonds . Because they contain
interchain disulfide bonds, procollagen andpC collagen (and type IX where present) migrate near the top of the gel . Lane 1, sample C30 ;
arrows indicate two possible forms ofpNaand below these is the a chain . Lane 2, humantype I procollagen ; arrow indicates the pNa(I)
chain and below this are the al, pNa2, and the a2 chains. Lane 3, chick type II procollagen ; arrow in lane 1 indicates the pNa chain
which lacks the cysteine-richdomain andbelow this is thea chain . Thechick sternal cartilage sample contains type XI, identified as previ-
ously described (Thomand Morris, 1991) . (D) CNBr peptide mapping of type II procollagen chains. Sample C30 was resolved by SDS-
PAGE on a 5% gel which is shown horizontally at the top. Electrophoretic migration was from right to left . Band 1 is the a chain, band
2 is pNIIB, band 3 ispCaandpNIIA, band 4 is pNCIIB and band 5, the slowest migrating, is thepresumptive pNCIIA . After fluorography,
each of the five bands was excised from the gel, digested with CNBr (see Materials and Methods), and analyzed by SDS-PAGE on a 10%
gel . The CNBr digestion pattern of pepsin extracted human type II collagen is shown flanking the radiolabeled samples . These samples
were electrophoresed on an identical SDS-PAGE and stained with Coomassie blue .
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1310Figure3 Expression oftypeIMmRNA in cartilage . Sections ofnewborn bovine articular cartilage (a and b) and human fetal digit cartilage
in the zone of chondrification (c and d) observed by both bright-field and dark-field microscopy. In a and c, positive hybridization is seen
in all cells sectioned and the cells can be aligned withthe grains visualized by dark field in b andd(for example, see arrows) . Upon hybridiza-
tion with the probe specific for type IIA, no positive hybridization was observed . In the dark-field photographs (b and d), the extent of
background hybridization can be observed between cells in the extracellular matrix . Exposure time was 1 wk . Bar, 16 um .
procollagens, advantage was taken of the fact that the
COOH-propeptide contains interchain disulfide bonds and
therefore procollagens containing this region, the pNC and
pC (>375,000 D), form covalent trimers. These large
trimers, without disulfide bond reduction, would migrate
near the top of the 5% SDS-PAGE gel . Under nonreducing
conditions, the pN procollagens still migrate in the middle
of the lane and are consequently more readily resolved . The
costal chondrocyte sample is compared to human type I
procollagen and chick sternal type II . Unlike theSDS-PAGE
gels shown in Fig . 2,A and B, multiple high molecular mass
bands can be observed near the top of the gel . The pN
procollagens are indicated by arrows and the mature alpha
chain migrates ahead ofthe procollagens. In the type I colla-
gen sample, the two predicted bands, cel(I) and pNa(I)
procollagen are observed . In the chicken sternal chondro-
cyte sample, two chains are also predicted and observed .
Note that the pNal(I) chain (lane 2) migrates more slowly
than the chick sternal pNal(II) (lane 3) presumably because
the pNal(I) chain contains cysteine-rich domain while the
chicken pNal(II) chain does not . Chicken sternal chondro-
cytes express type IIB procollagen because, as we have
shown previously and will show subsequently in this publi-
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cation, the predominant form of type II collagen in cartilage
mRNA is type IIB. In the costal chondrocyte sample, two
procollagen bands were observed which migrated at sizes
consistent with those of type HA and type IIB pN procol-
lagens.
To confirm that these procollagens were all forms of the
type II collagen, cyanogen bromide peptide analysis of each
gel band was performed (Fig . 2 D) . Each band (labeled 1-5
as in Fig . 2 A) yielded identical peptide maps characteristic
of type II collagen . The same pattern of peptides is observed
in both typeHA and type IIB procollagens due to a cleavage
at the methionine at amino acid three ofthe Gly-XY domain .
The NHz-propeptides cannot be detected . The five bands
can be now identified as : band 1, pNC of type HA ; band 2,
pNC of type IIB ; band 4, pN oftype IIB ; band 5, the mature
a chain . Band 3 (Fig . 2 D, and lane 3) is presumably a mix-
ture ofpC and pN (+ exon 2) and shows only one cyanogen
bromide peptide pattern .
Chondrocytes Synthesize TypeIM Procollagen
Previous results using Northern blot analysis of RNA indi-
cated that type IIB procollagen was the major collagen ex-
131 1Figure 4. Tissue expression of type 1, type IIA, and type IIB collagen mRNA in vertebral tissue observed by autoradiography of tissue
sections . Mid-sagittal sections ofvertebral column were hybridized with collagen-specific oligonucleotide probes : type I collagen (a) ; type
IIA collagen (b) ; type IIB (c) ; and all type II collagens (d) . In a-c, the insets represent a cross-sectional view hybridized with the same
probes . Dorsal side is on the right and the spinal cord has been removed . Autoradiographs were analyzed with the aid of aMOD Image
Analysis System without contrast enhancement. Type I procollagen is localized to the intervertebral area (a), while typeHA (b) apparently
surrounds the intervertebral area . Type IIB (c) is observed only within the centrum/vertebral body. In d, a probe specific for exon eight
of type II collagen shows the total distribution pattern of both type IIA and type IIB. Autoradiographs were exposed to film for 1-5 d .
Bar, 0.6 mm .
pressed in cultured bovine articular chondrocytes, cultured
human costal chondrocytes, and vertebral chondrocytes
(Ryan and Sandell, 1990) and fetal bovine auricular and cul-
tured fetal vertebral chondrocytes (Sandell, L . J. unpub-
lished observations) . Using oligonucleotide probes spanning
the junction of exon 1 and exon 2 (type IIA) or exon 1 and
exon 3 (type 11B), the expression of type II collagens was in-
vestigated by in situ hybridization to mRNA . These exon-
spanning probes are the same probes previously used in
Northern blot analysis : they are described in Materials and
Methods and indicated in the diagram in Fig . 1 . The results
shown in Fig . 3 demonstrate the abundant expression of type
IIB procollagen in fetal bovine articular cartilage (Fig . 3, a
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and b) and fetal human digit cartilage (Fig . 3, c and d) . These
tissues have morphological characteristics of cartilage, with
rounded lacunae, abundant hyaline extracellular matrix and
staining of the matrix with cresyl violet . Note that the cells
show strong hybridization with the oligonucleotide probe,
while the extracellular matrix shows only background hy-
bridization . These tissues showed no hybridization with
probes for type IIA procollagen or type I procollagen .
Localization of Type II Procollagen Expression
in Specific Pbpulations ofCells ofthe Developing
VertebralColumn
The presence of both type IIA and type IIB collagen mRNAs
1312has been demonstrated in populations of total RNA isolated
from fetal skeletal tissue and cultured costal chondrocytes .
In preparations ofisolatedRNA, Northern blots probed with
exon-spanning oligonucleotides indicated that there was rel-
atively more type IIB collagen mRNA in fetal skeleton than
type IIA collagen mRNA (Ryan and Sandell, 1990) . Since
the fetal skeleton is undergoing chondrogenesis and contains
cells at various stages in the developmental process, the cel-
lular localization of type IIA and type IIB collagen mRNAs
was examined by in situ hybridization . The same exon-
spanning oligonucleotide probes described previously were
used . At this time of development (57 d), the vertebra were
in a late stage of chondrification and the cells in the center
of the more developed cranial vertebra were likely hyper-
trophic . Type I collagen mRNA, characteristic of mesen-
chymal cells was present in the intervertebral area (Fig. 4 a) .
Localization of type II mRNAs revealed that type IIA was
localized in cells surrounding the cartilage (Fig. 4 b) in the
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Figure 5 . Serial sections ofver-
tebral tissue hybridized with
type I and type II collagen
probes, stained with cresyl
violet and observed by bright-
field optics (a) and dark-field
optics (b-d ) . Thetissue archi-
tecture can be seen in a . The
centrum/vertebral body (VB)
contains rounded cells pro-
ducing abundant extracellular
matrix that stains pink with
cresyl violet . The interver-
tebral area (IVA) is made up of
cells that are fibroblastic in
appearance and stainblue with
cresyl violet. No extracellular
matrix staining is observed
in the IVA . Type I collagen
mRNA is found in the inter-
vertebral area and surrounding
mesenchymal tissue in fibro-
blastic cells (b) . Type HA
mRNA hybridized to fibro-
blast-like cells surrounding
the intervertebral area (c) and
type IIB hybridized with cells
in the vertebral body. Expo-
sure times were : 3 d (b) ; 2 wk
(c) ; and 1 wk (d) . Bar, 0.2 mm .
prechondrogenic area that will eventuallybecome the articu-
lar endplate ofthe vertebral body while type IIB was present
primarily in cartilagenous tissue of the centrum (the precur-
sor of the vertebral body) where extracellular matrix was ac-
cumulated around the cells (Fig . 4 c) . Although most of the
tissue has been lost in the freezing procedure, some type IIA
can also be seen in the perichondrium remaining on the dor-
sal side of the vertebral body. The expression of collagens
was not radially symmetrical across the tissue (seen in the
cross sections) and appears to bemore abundant on the ven-
tral side of the vertebral body (sagittal section) at this plane
of sectioning . Fig. 4 d shows the tissue hybridized with a
probe for exon 8 of the COL2A1 gene . This exon is present
in both type IIA and type IIB procollagens and hybridizes
with all type II procollagen-synthesizing tissues as expected .
While the distribution of these collagen mRNAs was ob-
served in the film autoradiographs, more resolution was ob-
tained with emulsion autoradiography (Fig. 5) . Cells in the
1313Figure 6. Expression of type I and type II collagens in serial sec-
tions of vertebral column . Type I procollagenmRNA (a), type IIA
(b) and type IIB (c) . Intervertebral tissue is on the left and vertebral
tissue on the right . Type type I probe hybridizes only in the inter-
vertebral area to cells fibroblastic in appearance while the type IIA
hybridizes to a population of cells between the intervertebral area
and the vertebral body. Type 11B collagen is localized to the
rounded cells in the vertebral body. Exposure times were 3 d (a),
2 wk (b and c) . Bar, 16 tm.
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vertebral bodies (Fig. 5 a, VB) are rounded and the tissue
is cartilagenous in morphology, while the cells surrounding
the vertebral body and in the intervertebral area (IVA) have
an elongated, fibroblastic character. Type I procollagen
mRNA was synthesized by a distinct population of cells in
the intervertebral area while type IIB procollagen mRNA
was synthesized in cells of the vertebral body. Between the
intervertebral area and the cartilagenous zone, a population
of cells synthesized type IIA procollagen mRNA . Some hy-
bridization to type IIA is also apparent in the IVA . From this
data, it is not possible to determine whether a transitional
population of cells synthesizes both type IIA and type IIB
procollagen.
The cellular expression of types I, IIA, and IIB collagen
mRNAs is shown in Fig . 6. This area is thejunction between
the cartilagenous tissue of the centrum/vertebral body and
the intervertebral area . The progression from cells syn-
thesizing type I to those synthesizing type IIA collagen to
those synthesizing type IIB collagen can be seen . The partic-
ular morphology of the cells can also be observed . There ap-
pears to be an abrupt change in gene expression between the
type I procollagen-synthesizing cells of the intervertebral
area and the cells beginning to express type II procollagen .
The cells expressing type IIA collagen accumulate very little
extracellular matrix while the cells synthesizing type IIB col-
lagen are surrounded by stainable cartilagenous matrix .
From Fig . 6 b, it can be seen that the expression of type IIA
is confined to a subset of cells that do not synthesize type I
procollagen . However, it remains to be determined whether
the same cells can synthesize both type IIA and type IIB
procollagens. Certainly, the cells in the cartilagenous tissue
synthesize only type IIB procollagen . From these results a
three-dimensional model can be established where there is
a cartilagenous core structure made up of cells synthesizing
type IIB procollagen. The cartilagenous core is surrounded
by tissue synthesizing type IIA procollagen .
Coexpression ofa Cartilage Proteoglycan Aggrecan
with Type IIBProcollagen
In light of the differential expression oftype IIA and type IIB
procollagenmRNAs, we determined whethermRNA for the
other predominant cartilage extracellular matrix protein, the
chondroitin sulfate proteoglycan, was expressed in a distinct
pattern . Fig. 7 shows vertebral tissue hybridized with an oli-
gonucleotide encoding a region of the core protein of the
large cartilage aggregating proteoglycan, recently named
aggrecan (Doege et al., 1990) .
Expression ofTypeIIA Procollagen in
Nonchondrocytic Cells
During the analysis of type II procollagen expression in the
developing vertebral column, distinct expression of type II
collagen mRNA was observed in the cells forming the facet
joint and in the spinal ganglion . Fig . 8, a-c are cross sections
of the vertebral column in a plane through the spinal gan-
glion . The spinal ganglion shows positive hybridization to
the type IIA procollagen mRNA probe . Sagittal sections on
a plane through the spinal ganglion and facet joint are also
shown (Fig . 8, d and e) . The beginning of facet joint forma-
tion between the vertebral processes can be seen at the right
1314Figure 7 Autoradiograph ofthe localizat
body and other cartilagenous structures at the
in this photograph . In Fig . 8 e, i
ticularly high concentration of type HA procollagen
at the interface between the vertebral processes in the de-
veloping facet joint . Type 1113 is not detected in these cells,
but is abundant in the adjacent cartilage . Again, the cells
synthesizing type IIA had morphological features character-
istic of fibroblasts .
Discussion
Alternative splicing of pre-mRNA is now known to be
widespread importance for the generation of protein
forms . By this mechanism functions ranging" intracel-
lular and extracellular localization to enzyme activity can
be modulated by expression of
the
appropriate "in do-
main . Alternative splicing is also used quantitatively to reg-
ulate gene expression by generating truncated open reading
frames, or by regulating mRNA stability or translational
efficiency via variability in the untranslated regions . For type
11 we provide evidence that differential splicing
ofpre-mRNA regulates the expression of a protein domain
of
the
procollagIen molecule : that is, type IIA procollagen
contains the cysteine-rich 69-amino acid domain of the
NH,-propeptide and type IIB procollagen does not. We fur-
ther show
thatthe expression of typeHA andtype IIB procol-
lagens is tissue-specific in developing vertebrae. Typen
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IIB procollagen . Both probes hybridize to cells in the vertebral
W031 Bar .
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is the predominant type 11 collagen
e and is coexpressed with mRNA for the
cartilage-specific proteoglycan, aggrecan . The removal of
axon2 during processing ofpre-mRNA is correlated
with
a
change in cell morphology from spindle shaped to rounded
and the increased accumulation of extracellular matrix . This
differential expression of the N11 2-propeptide in a tissue-
specific manner raises the following intriguing questions .
What is the function of the NH2-propeptide in ripe 11 and
other interstitial collagens? Is there a role for type IIA
procollagen in development? What are the factors that regu-
late the differential splicing of type H procollagen mRNA?
Because of the relatively large alternatively spliced domain
of type H procollagen (69 amino acids), its homology with
other interstitial collagens, and the simplicity of the splicing
pattern {axon 2 : in or out), this system provides an excellent
model for study of the regulation of alternative splicing and
role of the N112-propeptide in interstitial collagens .
of TypeHA and TypeIM Procollagens
Both type IIA and type IIB procollagens are synthesized and
secreted by juvenile rastal chondrocyte cultures. Previously,
we had shown that these cultures synthesized substantial
amounts of both type HA and type IIB procollagenmMA
(" and Sandell, 1WN The high level4 synthesis 4 typeIIA by these cells was somewhat surprising due to the pre-
dominant expression oftype IIB in cartilage. However, these
cells were derived from the pectus excavatum operation in
which growing rib tips were removed, digested to free cells
from the matrix, and cultured . In the cultures, the presence
of type IIA could be accounted for by the cells undergoing
chondrogenesis in the tissue or, on the other hand, in culture,
these cells may be subject to less stringent controls permit-
ting the synthesis type IIA procollagen mRNA . Evidence for
the presence of both type RA and type IIB procollagen in
costal cartilage is provided by in situ hybridization studies
with fetal ribs where both probes for type IIA and type IIB
hybridized to the tissue (Sandell, L . J., and J . Sugai, unpub-
lished observations) .
From these studies, we do not know whether the type IIA
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Figure 8. Autoradiograph
showing differential expres-
sion of type I (a) and type IIA
(b) in serial cross sections of
a vertebral column . A section
of the same region embedded
in Epon for better resolution is
shown in (c) . Vertebral body
(VB) ; spinal ganglion (G) ;
spinal cord (SC) . The type
IIA probe hybridizes with a
region of the vertebral body
and the spinal ganglion ; the
type I probe hybridizes with
the surrounding tissue, but not
with the ganglion . d (bright
field) and e (dark field) show
sagittal sections through the
spinal ganglion, vertebral
process and facetjoint hybrid-
ized with type IIA collagen
probe. The type IIA probe hy-
bridizes to the ganglion and to
the cells surrounding the car-
tilagenous vertebral processes,
particularly in the developing
facet joint. Exposure times
were 1 wk (a), 3 d (b), 2 wk
(e) . Bars, 0.2 mm .
and type IIB procollagens form homotrimers or hetero-
trimers. However, because type IIA and type IIB procolla-
gens are synthesized primarily by different cell, and procol-
lagen trimers are formed intracellularly, we assume that both
type IIA and type IIB procollagens usually exist as homo-
trimers. A great deal of evidence indicates that the0 chain
oftype XI collagen is a product ofthe COL2A1 gene, imply-
ing that a type II procollagen chain can be incorporated into
more than one type ofcollagen molecule (Burgeson and Hol-
lister, 1979) . When both type XI and type II collagen were
isolated from the same cartilage tissue and separated on
SDS-PAGE, the intact «3 chain appeared to be -10,000 D
larger than the intact type II collagen chain (Wu, J., and D.
Eyre, University of Washington, personal communication) .
This 0 chain in bovine fetal cartilage is now known to be
1316identical to the type IIB procollagen shown in this study : the
0 chainis larger than the a chain derived from type II colla-
gen because the 0 chain is not cleaved by the processing
proteinase that removes the NH2-propeptide from the type
11 molecule and, therefore, the amino acid sequence begins
at the site of signal peptide cleavage. At this time, we do not
know whether the chondroblasts or other type IIA collagen-
containing tissues also express type XI collagen and conse-
quently, we do not know whether type IIA collagen can also
be incorporated into the type XI molecule.
Function of the NHZ-Propeptide
We have established the fact that two type II procollagen
chains, differing in the presence or absence of the cysteine-
rich domain of the N112-propeptide can be transcribed,
translated, and secreted in chondrocyte cultures. As shown
in Fig. 1, the N112-propeptide is characterized by a short
globular domain followed by the interchain disulfide region,
then a Gly-XY domain. In the type I collagen molecule,
there are three chains: two cd(I) and one a2(I). The al(I)
chain contains the cysteine-rich domain while the a2(I)
chain, due to a truncated exon in the COL1A2 gene, does not
contain the cysteine-rich domain (see Sandell and Boyd,
1990, for a detailed comparison) . Consequently, in overall
structure of the procollagen, the type HA chain resembles
the al(I) polypeptide and the type IIB chain resembles the
a2(I) polypeptide. Cleavage of the NHZ- and 000H-
terminal extension peptides generally occurs extracellularly
by specific neutral proteases presumably prior to collagen
fibrillogenesis. In collagens type I and II, the removal of the
propeptides is concomitant with fibrillogenesis. In types III
(Fleischmajer et al., 1981) and V collagen (Fessler et al.,
1981), there is evidence for retention of the NHZ-propeptide
in the mature collagen molecule. The propeptide may func-
tion after cleavage from the procollagen as the trimeric type
I NHZ-propeptide has been isolated from bovine bone
(Fisher et al., 1983) and is present in serum indicating that
the NHZ-propeptide may have a role independent of its
function in the intact procollagen.
Two major functions have been suggested for the NHZ-
propeptide: (a) it plays a role in fibrillogenesis and (b) it
plays a role in feedback inhibition of collagen synthesis. For
example, Fleischmajer et al . (1985) reported that the di-
ameter of collagen type I fibers was decreased from 35-40
to 20-30 nm by the presence of pN procollagen and that po-
lymerization of the thin fibrils involved polymerization of
pN collagen. The effect is thought to be physiologically rele-
vant as they found significant amounts of pN collagen in
chicken embryonic skin and showed that the ratio of pN
procollagen to processed collagen varies with age, presum-
ably due to different levels of N-proteinase activity. The role
of the N112-propeptide in feedback regulation of collagen
synthesis has been suggested by studies on dermatosporactic
sheep and the humandisease Ehlers-Danlos Syndrome Type
IV In both of these diseases, the NHZ-propeptide is re-
tained in the mature collagen molecule and increased synthe-
sis of both type I and type III collagens was observed. When
isolated N142-propeptides of type I and type III collagen
were added directly to cultured fibroblasts, collagen synthe-
sis was inhibited (Weistner et al., 1979). Other in vitro
studies support a function for the propeptides in regulation
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of biosynthesis that may be mediated by a cell surface recep-
tor (Weistner et al., 1979 ; Paglia et al ., 1981; Horlein et al.,
1981; Wu et al., 1986, 1991; Fleischmajer et al ., 1990). In
addition, there may be as yet uncharacterized interactions of
the collagen NHZ-propeptide with other extracellular ma-
trix molecules.
Chondrogenesis
The vertebral column is derived from mesenchymal cells
that arise from the sclerotomes of the somites. Each sclero-
tome consists oftwo regions: loosely arranged cells cranially
and densely packed cells caudally. It is commonly thought
that the annulus fibrosis of the intervertebral disc is derived
from the densely packed cells which move cranially to align
with the center of the myotome (Moore, 1988) . The mesen-
chymal cells of the centrum are derived from the remaining
densely packed cells, which fuse with the loosely arranged
cells of the caudal sclerotome. Consequently, the centrum
develops from two adjacent sclerotomes. Chondrification
begins in two lateral centers of the centrum during the sixth
week of embryogenesis and continues until the centers fuse
to form the cartilagenous centrum . The chondrocytes in the
center of the centrum/vertebral body begin to hypertrophy
and ossification begins soon thereafter. The cells surround-
ing the centrum/vertebral body that express exon 2 are con-
sidered to serve as chondrogenic zones for the centra (O'Ra-
hilly and Gardner, 1978) . Consequently, the splicing out of
exon 2 may mark a new stage in chondrogenesis. This event
could be responsible for determining whether type II mRNA
containing cells proceed to chondrogenesis or proceed along
another developmental pathway. The factor(s) necessary to
remove exon 2 may be part of the chondrogenic phenotype
and the control ofthis switch may be causal in chondrogene-
sis. On the other hand, the factors necessary for control may
be present in the prechondrocytesdirecting inclusion ofexon
2 . The mesenchymal and fibroblast-like cells previously
found to contain type II collagen mRNA (Hayashi et al.,
1986) likely express the type IIA procollagen form that con-
tains the N112-propeptide, while the chondrocytic cells ex-
press the alternatively spliced type IIB form. These cells,
called the zone of progenitor cells in mouse neonatal con-
dyles, incorporate [3H]thymidine at a higher rate than sur-
rounding cell populations (Shurtz-Swinski et al., 1989) . The
distinct cellular localization of the two different type II
procollagens indicates that they may play different functional
roles in distinct tissues. The expression of the NHZ-
propeptideis correlated with a low level of extracellular ma-
trix deposition, while removal of exon 2 is correlated with
increased synthesis and accumulation of the characteristi-
cally abundant cartilage matrix. The expression of type IIA
procollagen mRNA present in the cartilage surrounding the
vertebral body persists at leastup to 122 d ofgestation (San-
dell, L. J., and J. Sugai, unpublished observations) . This
localization of type IIA procollagen during chondrogene-
sis is remarkably similar to the expression of the 6.4-kb
form of cytotactin mRNA, also an alternatively spliced spe-
cies (Prieto et al., 1990), in embryonic chicken vertebral
column.
Type IIA procollagen is also particularly abundant in the
regions destined to form the articular cartilage ofjoint tissue
both in the cartilage surrounding the vertebral bodies (Fig.
13174) and in the cartilage joining the dorsal vertebral processes
(Fig. 8) . Type IIA procollagen distribution compared to type
IIB procollagen distribution indicates that type IIA may be
particularly localized in interface regions. Although a highly
speculative suggestion, it is possible that type IIA procolla-
gen expressed by these noncartilagenous cells functions to
identify the region of joint formation.
These results have important implications for the regula-
tion ofthe chondrocyte phenotype. It has previously been as-
sumed that the phenotype was established by regulation at
the level of transcription. Evidence showing increased ac-
cumulation of type II collagen mRNA and core protein as
chondrogenesis proceeded in vitro (Vuorio et al ., 1982) sup-
ported the theory that as mesenchymal cells differentiated
into chondrocytes, both type II collagen and proteoglycan
gene expression increased coordinately. Upon closer exami-
nation, however, it was found quite consistently that the ex-
pression of type II mRNA preceded overt chondrogenesis
(Kravis and Upholt, 1985; Kosher et al., 1986) and that
some nonchondrocytic cells surrounding chondrogenic tis-
sue contained type II procollagen mRNA (Hayashi et al.,
1986) . We would predict that the expression of type II colla-
gen in fibroblastic cells (Hayashi et al., 1986) as well as the
prechondrogenic expression of mRNA established by Ko-
sher et al ., (1986) and Kravis and Upholt (1985) is due to
the expression of type IIA . Therefore, the expression of
aggrecan may be coordinated with a change in the mRNA
splice pattern of type II collagen in addition to an increase
in transcription. It will be necessary to define the isoform of
type II collagen synthesized in a variety of developmental
and repair systems as all previous studies on type II collagen
mRNA and type II collagen, in which the collagen was
identified by cyanogen bromide mapping or type II-specific
antibodies, would not have detected a difference between
type IIA and type IIB procollagens.
Alternative splicing of pre-mRNA appears to play a role
in development. Expression of alternatively spliced forms
of fibronectin are correlated with development (ffrench-
Constant and Hynes, 1988) and wound healing (ffrench-
Constant et al., 1989), however, the function of these alter-
natively spliced forms and their existence as fibronectin
molecules have not been determined. In chondrocytes, two
examples of alternative exon usage have been described that
are relevant to the cartilage phenotype. First, type IX colla-
gen, originally thought to be cartilage specific, is expressed
in developing cornea, although a different promoter is used
and a specific protein domain is removed (Nishimura et al.,
1989; Muragaki et al ., 1990) . Secondly, Adams and col-
leagues (Bennett et al., 1989 ; Bennett and Adams, 1990)
have shown that the COMA2 gene is expressed in chondro-
cytes, but again, a different promoter is employed yielding
a protein product that is not collagenous. It has been sug-
gested thatboth the alternative COLlA2 product (Bennettand
Adams et al ., 1990) and the type I collagen NH2-propep-
tide (Wu etal., 1986) may function to inhibit collagen syn-
thesis at a pretranslational level. Taken together, a pattern of
events is beginning to emerge which determinesthe cartilage
phenotype. These events are likely controlled by regulatory
elements in the nucleus either acting on the DNA directly or
on processing of pre-mRNA. Investigation of these nuclear
events will broaden our understanding of chondrogenesis,
cartilage repair processes, and skeletal dysplasias.
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Expression ofType IIProcollagen mRNA in
Nonchondrogenic Embryonic 7Yssue
The importance of a change in type II procollagen form is
revealed by the expression of type HA procollagen in non-
chondrocytic tissues and expression of type IIB procollagen
in chondrocytes. A cell may not have the ability to exclude
exon 2 by alternative splicing either due to the lack of a
specific splicing factor or repression of alternative splicing
and, as a consequence, proceed along with a completely
different developmental route. Indeed, von tier Mark and
colleagues (von tier Mark et al., 1976) have shown that type
II collagen accumulates in the cell-free region adjacent to the
embryonic notochord into which somitic sclerotomal cells
expand prior to differentiating into vertebral cartilage. We
have observed type HA procollagen mRNA, in situ, in the
notochordal remnants of the developing intervertebral disk
nucleus pulposus. The expression of type II procollagen in
noncartilagenous portions of the embryo and spinal gan-
glion was surprising. However, in early embryogenesis, the
notochord induces the overlying ectoderm to form the neural
plate. The neural ectoderm differentiates into the central
nervous system and spinal cord and cells from the neural ec-
toderm migrate to formthe spinal ganglia, the medulla ofthe
adrenal gland, pigment cells, and other connective tissues of
the head and neck. Possibly, in contrast to mature tissues,
type II procollagen plays a different, more ubiquitous role
during development. Indeed, Thorogood et al. (1986), have
found type II collagen at the epitheliomesenchymal interface
and suggested that type II collagen may be instructive in
future differentiation of the cartilagenous neurocranium.
Finally, the recent findings of Kosher and Solursh (1989)
showing immunoreactive type II collagen in a variety of
embryonic basement membranes may be related to the ex-
pression of type IIA at the interfaces of developingvertebral
column. Taken together, these results suggest the possibility
thattype II collagen expression in these areas is actually type
HA procollagen and chondrogenesis is dependent on the
removal of exon 2 to synthesize type IIB procollagen. These
results indicate that type II procollagen may play a more
widespread role than previously suspected, particularly in
developing tissues.
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